Cargando…
Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
Tropomyosin receptor kinase A (TrkA) protein is a receptor tyrosine kinase encoded by the NTRK1 gene. TrkA signaling mediates the proliferation, differentiation, and survival of neurons and other cells following stimulation by its ligand, the nerve growth factor. Chromosomal rearrangements of the NT...
Autores principales: | Lee, Hyo Jeong, Moon, Yeongyu, Choi, Jungil, Heo, Jeong Doo, Kim, Sekwang, Nallapaneni, Hari Krishna, Chin, Young-Won, Lee, Jongkook, Han, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252884/ https://www.ncbi.nlm.nih.gov/pubmed/35264466 http://dx.doi.org/10.4062/biomolther.2021.195 |
Ejemplares similares
-
Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells
por: KIM, DONG CHUL, et al.
Publicado: (2016) -
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer
por: Lee, Hyo Jeong, et al.
Publicado: (2021) -
TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023) -
Characterization of the aminopyridine derivative KRC-180 as a JAK2 inhibitor
por: Yoon, Kyoung Bin, et al.
Publicado: (2017) -
Sensory Neuron-Specific Deletion of Tropomyosin Receptor Kinase A (TrkA) in Mice Abolishes Osteoarthritis (OA) Pain via NGF/TrkA Intervention of Peripheral Sensitization
por: O-Sullivan, InSug, et al.
Publicado: (2022)